"Designing Growth Strategies is in our DNA"

Ear Infection Treatment Market Size, Share and Global Trend By Infection Type (Outer Ear, Middle Ear, Inner Ear), By Drug Type (Analgesics, Antibiotics, Nonsteroidal Anti-Inflammatory Drugs, Others), By End User (Hospitals, ENT Clinics, Ambulatory Surgery Centers, Others) and Geography Forecast till 2021-2028

Region : Global | Report ID: FBI101125 | Status : Ongoing

 

KEY MARKET INSIGHTS

Viruses and bacterias are highly responsible for causing ear infections, moreover children are more susceptible to contracting ear infections than adults. Otitis media with effusion (OME) and acute otitis media (AOM) are some of the types of ear infections commonly observed amongst the general population. Ear infections exhibit symptoms such as inflammation, hearing changes, fever, headache, swelling, and nausea.


Acute infections are painful but for a short period of time, but chronic infections can cause permanent damage to the middle ear and inner ear. According to Centres for Disease Control and Prevention (CDC), each year, an estimated 4 to 5 out of every 1000 children in the U.S. are susceptible to ear infection leading to hearing loss.


To gain extensive insights into the market, Request for Customization


The significant prevalence of ear infection across the globe is anticipated to offer growth opportunity for the global ear infection market during the forecast period. Moreover, growth in certain risk factors such as smoking, exposure to bacteria and viruses and climate change may expect to boost the incidence of ear infection, which will eventually fuel the growth of the global ear infection market by 2026.


However, certain factors such as higher costs associated with the ear infection treatment & medications and lack of expertise in emerging nations are anticipated to hamper the growth of the global ear infection market during the forecast period.


Key Players Covered


Some of the major companies that are present in the global ear infection treatment market are American Diagnostic Corporation, Pfizer plc, Heine USA Ltd., Welch Allyn, TORQUE PHARMACEUTICALS PVT. LTD., Medtronic, Intersect ENT, Inc., Olympus Corporation, Grace Medical, and others.


SEGMENTATION


























SEGMENTATION


DETAILS

By Infection Type



· Outer Ear


· Middle Ear


· Inner Ear



By Drug Type



· Analgesics


· Antibiotics


· Nonsteroidal Anti-Inflammatory Drugs


· Others



By End User



· Hospitals


· ENT Clinics


· Ambulatory Surgery Centres


· Others



By Geography



· North America (USA and Canada)


· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)


· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)


· Latin America (Brazil, Mexico and Rest of Latin America)


· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



 


Among the segmentation, antibiotics among the drug type segment is anticipated to hold a considerable share of the global ear infection treatment market owing to higher adoption and availability of antibiotics.


Key Insights



  • Epidemics of ear infection for key countries

  • Recent industry developments such as partnerships, mergers, and acquisitions

  • Key performance indicators for global ear infection treatment market


Regional Analysis


North America is projected to dominate the global ear infection treatment market owing to the higher prevalence of ear infection coupled with the availability of healthcare resources. Moreover, advances in diagnostic techniques and awareness amongst patients are expected to fuel the growth of the global ear infection treatment market during the forecast period. Asia Pacific region holds huge potential for growth of the global ear infection treatment market due to a higher rate of bacterial and viral ear infections. Additionally, the rising prevalence of otitis media including acute and chronic forms of the disease in emerging nations offers a lucrative environment for the growth of the ear infection market in the Asia Pacific.


Key Industry Developments



  • In May 2016, FDA approved new drug discovered by Arbor Pharmaceuticals, Otovel for the treatment of acute otitis media. The newly formulated drug is combination of ciprofloxacin and fluocinolone acetonide.

  • In December 2015, antibacterial drug, Otiprio, developed by Otonomy Inc. got FDA approval for the treatment of inflammatory ear disease in children. The drug was tested on paediatric patients who were suffering from middle ear infection.


Ear Infection Treatment Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • $4850
    $6850
    $8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Roche
uniliver
Ansell
Pfizer
Jubilant

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X